MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
33.79%
Quick Ratio
33.79%
Debt to Asset Ratio
3.53%
Unit: Dollar
Assets Breakdown
    • Cash and investments held in tru...
    • Cash
    • Prepaid expenses
Liabilities Breakdown
    • Ordinary shares subject to possi...
    • Accumulated deficit
    • Deferred underwriting fee payabl...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
-
-
223
315,087
Due from sponsor-Sponsor
-
-
-
566,269
Cash
174,974
347,720
-
-
Prepaid expenses
42,849
4,041
25,814
15,000
Total current assets
217,823
351,761
26,037
896,356
Cash and investments held in trust account
513,882,333
509,373,650
504,933,800
500,109,355
Total non-current assets
513,882,333
509,373,650
504,933,800
-
Total assets
514,100,156
509,725,411
504,959,837
501,005,711
Accounts payable
12,253
49,166
99,359
4,592
Accrued expenses
69,159
53,957
88,343
5,843
Accrued offering costs
113,162
113,162
113,162
113,162
Over-allotment liability
-
-
-
553,748
Promissory notes
450,000
450,000
-
-
Total current liabilities
644,574
666,285
300,864
677,345
Deferred underwriting fee payable
17,500,000
17,500,000
17,500,000
17,500,000
Total non-current liabilities
17,500,000
17,500,000
17,500,000
-
Total liabilities
18,144,574
18,166,285
17,800,864
18,177,345
Ordinary shares subject to possible redemption, 50,000,000 shares at redemption value of 10.28 and 10.10 per share as of june 30, 2026 and december 31, 2025, respectively
513,882,333
509,373,650
504,933,800
500,109,355
Ordinary shares, 0.0001 par value 220,000,000 shares authorized 13,700,000 shares issued and outstanding, excluding 50,000,000 shares subject to redemption as of june 30, 2026 and december 31, 2025
1,369
1,369
1,369
1,557
Accumulated deficit
-17,928,120
-17,815,893
-17,776,196
-17,282,546
Total shareholders deficit
-17,926,751
-17,814,524
-17,774,827
-17,280,989
Total liabilities, ordinary shares subject to possible redemption, and shareholders deficit
514,100,156
509,725,411
504,959,837
501,005,711
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and investmentsheld in trust account$513,882,333 Cash$174,974 Prepaid expenses$42,849 Total non-currentassets$513,882,333 Total current assets$217,823 Total assets$514,100,156 Accumulated deficit-$17,928,120 Total liabilities,ordinary shares subject...$514,100,156 Total shareholdersdeficit-$17,926,751 Ordinary shares, 0.0001par value...$1,369 Ordinary shares subjectto possible...$513,882,333 Total liabilities$18,144,574 Total non-currentliabilities$17,500,000 Total currentliabilities$644,574 Deferred underwritingfee payable$17,500,000 Promissory notes$450,000 Accrued offering costs$113,162 Accrued expenses$69,159 Accounts payable$12,253

Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II Corp. (DMII)